Tedesco-Silva H - Search Results

1

Exposure-efficacy relationships of a fingolimod-everolimus regimen in kidney transplant patients at risk for delayed graft function.

Kovarik JM, Tedesco-Silva H, Lorber MI, Foster C. Kovarik JM, et al. Transplant Proc. 2006 Dec;38(10):3479-82. doi: 10.1016/j.transproceed.2006.10.084. Transplant Proc. 2006. PMID: 17175310 Clinical Trial.

2

Exposure-response relationships for everolimus in de novo kidney transplantation: defining a therapeutic range.

Kovarik JM, Kaplan B, Tedesco Silva H, Kahan BD, Dantal J, Vitko S, Boger R, Rordorf C. Kovarik JM, et al. Transplantation. 2002 Mar 27;73(6):920-5. doi: 10.1097/00007890-200203270-00016. Transplantation. 2002. PMID: 11923693 Clinical Trial.

3

Safety and efficacy of sirolimus in kidney transplant patients and in patients with coronary artery disease undergoing angioplasty.

Tedesco Silva H Jr, Felipe CR, Machado PG, Garcia R, Motegi S, Hosaka BH, Hanzawa NM, Park SI, Casarini D, Lima VC, Franco M, Medina-Pestana JO. Tedesco Silva H Jr, et al. Transplant Proc. 2003 May;35(3 Suppl):177S-180S. doi: 10.1016/s0041-1345(03)00232-x. Transplant Proc. 2003. PMID: 12742493 Clinical Trial.

4

FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation.

Tedesco-Silva H, Mourad G, Kahan BD, Boira JG, Weimar W, Mulgaonkar S, Nashan B, Madsen S, Charpentier B, Pellet P, Vanrenterghem Y. Tedesco-Silva H, et al. Transplantation. 2004 Jun 27;77(12):1826-33. Transplantation. 2004. Corrected and republished in: Transplantation. 2005 Jun 15;79(11):1553-60.. PMID: 15223899 Corrected and republished. Clinical Trial.

5

FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation.

Tedesco-Silva H, Mourad G, Kahan BD, Boira JG, Weimar W, Mulgaonkar S, Nashan B, Madsen S, Charpentier B, Pellet P, Vanrenterghem Y. Tedesco-Silva H, et al. Transplantation. 2005 Jun 15;79(11):1553-60. Transplantation. 2005. PMID: 15940045 Clinical Trial.

6

12-month safety and efficacy of everolimus with reduced exposure cyclosporine in de novo renal transplant recipients.

Tedesco-Silva H Jr, Vitko S, Pascual J, Eris J, Magee JC, Whelchel J, Civati G, Campbell S, Alves-Filho G, Bourbigot B, Garcia VD, Leone J, Esmeraldo R, Rigotti P, Cambi V, Haas T; 2306 and 2307 study groups. Tedesco-Silva H Jr, et al. Transpl Int. 2007 Jan;20(1):27-36. doi: 10.1111/j.1432-2277.2006.00414.x. Transpl Int. 2007. PMID: 17181650 Free article. Clinical Trial.

7

Randomized controlled trial of FTY720 versus MMF in de novo renal transplantation.

Tedesco-Silva H, Pescovitz MD, Cibrik D, Rees MA, Mulgaonkar S, Kahan BD, Gugliuzza KK, Rajagopalan PR, Esmeraldo Rde M, Lord H, Salvadori M, Slade JM; FTY720 Study Group. Tedesco-Silva H, et al. Transplantation. 2006 Dec 27;82(12):1689-97. doi: 10.1097/01.tp.0000251718.95622.b3. Transplantation. 2006. PMID: 17198261 Clinical Trial.

8

FTY720 versus mycophenolate mofetil in de novo renal transplantation: six-month results of a double-blind study.

Tedesco-Silva H, Szakaly P, Shoker A, Sommerer C, Yoshimura N, Schena FP, Cremer M, Hmissi A, Mayer H, Lang P; FTY720 2218 Clinical Study Group. Tedesco-Silva H, et al. Transplantation. 2007 Oct 15;84(7):885-92. doi: 10.1097/01.tp.0000281385.26500.3b. Transplantation. 2007. PMID: 17984842 Clinical Trial.

9

Mycophenolate mofetil vs. sirolimus in kidney transplant recipients receiving tacrolimus-based immunosuppressive regimen.

Sampaio EL, Pinheiro-Machado PG, Garcia R, Felipe CR, Park SI, Casarini DE, Moreira S, Franco MF, Tedesco-Silva H Jr, Medina-Pestana JO. Sampaio EL, et al. Clin Transplant. 2008 Mar-Apr;22(2):141-9. doi: 10.1111/j.1399-0012.2007.00756.x. Clin Transplant. 2008. PMID: 18339132 Clinical Trial.

10

Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.

Schena FP, Pascoe MD, Alberu J, del Carmen Rial M, Oberbauer R, Brennan DC, Campistol JM, Racusen L, Polinsky MS, Goldberg-Alberts R, Li H, Scarola J, Neylan JF; Sirolimus CONVERT Trial Study Group. Schena FP, et al. Transplantation. 2009 Jan 27;87(2):233-42. doi: 10.1097/TP.0b013e3181927a41. Transplantation. 2009. PMID: 19155978 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

206 results

Search Page

Filters